Kodiak Sciences, Inc. (KOD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cue Biopharma, Inc.

Bionano Genomics, Inc.

Immunome, Inc.

CARA Therapeutics, Inc.

NGM Biopharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

Kodiak Sciences, Inc.

Cyteir Therapeutics, Inc.

Anixa Biosciences, Inc.

IO Biotech, Inc.

Omega Therapeutics, Inc.

Why is Kodiak Sciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Kodiak Sciences, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Kodiak Sciences, Inc.

452.98%

11.27

136.06%

S&P 500

21.51%

1.63

13.19%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-163.07%

EBIT to Interest (avg)

-234.55

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

95.34

EV to EBIT

-10.39

EV to EBITDA

-11.80

EV to Capital Employed

36.25

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-348.88%

ROE (Latest)

-909.32%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -114.89 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

EPS(Q)

Highest at USD -0.94

-6What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -146.94 MM

NET PROFIT(9M)

At USD -176.35 MM has Grown at -22.8%

ROCE(HY)

Lowest at -208.8%

Here's what is working for Kodiak Sciences, Inc.

Net Profit

Higher at USD -114.89 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.94

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Kodiak Sciences, Inc.

Operating Cash Flow

Lowest at USD -146.94 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)